Immune Response falls on arbitration news

IMNR was off $1.438 (23 percent) to $4.625 on Wednesday and lost $39.4 million of its market cap, which dropped to $126.8 million from $166.2 million, following Tuesday's announcement that it

Read the full 314 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE